Integral Diagnostics (ASX:IDX) ROCE % : -15.35% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Integral Diagnostics ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Integral Diagnostics's annualized ROCE % for the quarter that ended in Dec. 2023 was -15.35%.

Integral Diagnostics ROCE % Historical Data

The historical data trend for Integral Diagnostics's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integral Diagnostics ROCE % Chart

Integral Diagnostics Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROCE %

Get a 7-Day Free Trial

17.09

11.14

9.95

5.16

6.72

Integral Diagnostics Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial												6.70	3.84	7.43	5.82	-15.35

Integral Diagnostics ROCE % Calculation

Integral Diagnostics's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	48.998	/	( ( (783.015 - 80.004)	+	(839.011 - 82.667) )	/ 2 )
	=	48.998	/	( (703.011	+	756.344)	/ 2 )
	=	48.998	/	729.6775
	=	6.72 %

Integral Diagnostics's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-108.7	/	( ( (839.011 - 82.667)	+	(745.797 - 86.071) )	/ 2 )
	=	-108.7	/	( ( 756.344	+	659.726 )	/ 2 )
	=	-108.7	/	708.035
	=	-15.35 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Integral Diagnostics (ASX:IDX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Integral Diagnostics ROCE % Related Terms

Thank you for viewing the detailed overview of Integral Diagnostics's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Integral Diagnostics (ASX:IDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integral Diagnostics Ltd (ASX:IDX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

ITGDF:USA

Address

45 William Street, Suite 9.02, Level 9, Melbourne, VIC, AUS, 3000

Website

http://www.integraldiagnostics.com.au

Integral Diagnostics is Australia's fourth-largest diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.